Skip to main content
How strong is your knowledge on continuous glucose monitors? Take the quiz to test your expertise!
>
Adrenal Disorders
Resource Center
Menu
Menu
Main navigation
Home
Education
Featured Topics
Acute Hepatic Porphyria
Agitation in Alzheimer Disease
COVID-19
Danon Disease
Depression Care 360
Diabetes
Diabetes Technology
Digital Health Solutions in Diabetes
Dry Eye Disease
Endometrial Cancer
GSK Partner Spotlight
HIV Management
IgG4-Related Disease
Lupus Nephritis
MASH
Pain Management
Type 2 Diabetes
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Multidisciplinary Roundtables
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Heart Association Scientific Sessions
American Society of Hematology Annual Meeting & Exposition
Consultant360's Practical Updates in Primary Care
Conference on Retroviruses and Opportunistic Infections
Infectious Diseases Society of America’s IDWeek
International AIDS Conference
Society of Hematologic Oncology's Annual Meeting
Clinical Updates
Allergic Asthma
Alzheimer Disease
Cardiovascular Disease
COVID-19
Endometrial Cancer
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Publication
About Consultant
Advertising With Consultant360
Author Guidelines
Call for Papers
Case Report Templates
Consultant Current Issue
Consultant Archive
Consultant Early View
FAQ
Get Permissions
Job Board
Get Permissions
Search
Contact
Login
Menu
Menu
Main navigation
Home
Education
Featured Topics
Acute Hepatic Porphyria
Agitation in Alzheimer Disease
COVID-19
Danon Disease
Depression Care 360
Diabetes
Diabetes Technology
Digital Health Solutions in Diabetes
Dry Eye Disease
Endometrial Cancer
GSK Partner Spotlight
HIV Management
IgG4-Related Disease
Lupus Nephritis
MASH
Pain Management
Type 2 Diabetes
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Multidisciplinary Roundtables
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Heart Association Scientific Sessions
American Society of Hematology Annual Meeting & Exposition
Consultant360's Practical Updates in Primary Care
Conference on Retroviruses and Opportunistic Infections
Infectious Diseases Society of America’s IDWeek
International AIDS Conference
Society of Hematologic Oncology's Annual Meeting
Clinical Updates
Allergic Asthma
Alzheimer Disease
Cardiovascular Disease
COVID-19
Endometrial Cancer
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Publication
About Consultant
Advertising With Consultant360
Author Guidelines
Call for Papers
Case Report Templates
Consultant Current Issue
Consultant Archive
Consultant Early View
FAQ
Get Permissions
Job Board
Get Permissions
Blood Pressure
Quiz: Primary Aldosteronism Guideline
Copied to clipboard
<section><h2><h2><strong>Quiz: Primary Aldosteronism Guideline</strong></h2></h2><p><p>How well do you know the Endocrine Society's clinical practice guideline on the management of primary aldosteronism? Click the button below to start the quiz.</p></p></section><section><h2><h2><strong>What imaging modality should be used as the initial study in subtype testing and to exclude adrenocortical carcinoma in all patients with primary aldosteronism (PA)?</strong></h2></h2></section><section><h3><h2><strong>When surgical treatment is feasible and desired by a patient, what does the guideline recommend to distinguish between unilateral and bilateral adrenal disease?</strong></h2></h3></section><section><h3><h2><strong>What does the guideline recommend as the primary agent in patients with PA due to bilateral adrenal disease?</strong></h2></h3></section><section><h3><h2><strong>True or False: In patients with glucocorticoid remediable aldosteronism (GRA), the guideline recommends administering the highest dose of glucocorticoid to lower adrenocorticotropic hormone (ACTH) and thus normalize blood pressure and potassium levels as the first-line treatment.</strong></h2></h3></section><section><h2><h2><strong>Better luck next time!</strong></h2></h2></section><section><h3><h2><strong>Nice job!</strong></h2></h3></section>
